Bellerophon Therapeutics (BLPH, $0.01) was a top loser over the last three months, falling -6 to $0.01 per share. A.I.dvisor analyzed 861 stocks in the Biotechnology Industry for the 3-month period ending December 12, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.